LTGO
Latigo Biotherapeutics, Inc.
16.70$
-0.1%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
Latigo Biotherapeutics, Inc. (LTGO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -98 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2024 | 2025 |
|---|---|---|
| -51 | -98 | |
| 0.2 | 0.2 | |
| 2.8 | 6.7 | |
| 6.9 | 2.5 | |
| 0.1 | 0.1 | |
| 0.6 | 149 | |
| -50 | 52 | |
| -51 | -98 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.